Connecticut Affiliate of the DDNA

Diazepam Nasal Spray Virtual Presentation

Posted over 4 years ago

This announcement has 6 attachments:
VALTOCO (2.9 MB)

Neurelis, a neuroscience-based specialty pharmaceutical company, will be hosting a presentation on the FDA approved VALTOCO® (Diazepam Nasal Spray) Seizure Rescue Treatment.

The program is scheduled for March 24 at 4:00pm and will be presented by Dr. Jurriaan Peters from Boston Children’s Hospital.

Please see the registration link here: https://NeurelisMETS.com/VAL-ONL-VIR-NOM-00339